FOLD vs TDG · rev $528.3M vs P/E 41, rev $8.83B
Amicus Therapeutics Inc (FOLD) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
FOLD currently screens at market cap $1.80B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the FOLD and TDG stock pages for the full models.
Not investment advice.